Macrocyclic ligands with pendant chelating moieties and complexes thereof
The invention relates to ligands and complexes of metal ions with the ligands useful in various applications, including therapeutic and diagnostic applications.
1. A compound according to the formula:
wherein
L 1a is C 2 alkyl substituted with L x6 ;
L x6 is selected from a linker to a reactive functional group and a linker to a targeting moiety;
L 1b , L 1c are each C(O);
L 2d and L 2e are independently selected from a bond, C(O), substituted or unsubstituted alkyl and substituted or unsubstituted heteroalkyl;
L 2a and L 2c are independently selected from substituted or unsubstituted C 2 , C 3 and C 4 alkyl;
L 2b is selected from unsubstituted C 2 , C 3 , C 4 and C 5 alkyl;
L 2f and L 2g are independently selected from a bond, substituted or unsubstituted alkyl and substituted or unsubstituted heteroalkyl;
R L1 , R L2 , R L3 , and R L4 are independently selected from H, substituted and unsubstituted alkyl and substituted and unsubstituted heteroalkyl; and
A p1 and A p2 are independently selected pendant chelating moieties.
2. The compound according to claim 1 , having the formula:
3. The compound according to claim 1 wherein each of A P1 and A P2 are each:
4. The compound of claim 1 , wherein L′ has the structure:
—L 11 —F X ,
wherein L 11 is selected from a bond, acyl, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl and substituted or unsubstituted heteroaryl; and
F X is selected from a reactive functional group, a protected functional group, and a targeting moiety.
5. The compound according to claim 4 , wherein —L 11 —F X has the structure:
wherein
R L is selected from substituted or unsubstituted alkyl, and substituted or unsubstituted heteroalkyl; and
F X is selected from a reactive functional group, a protected functional group, and a targeting moiety.
6. The compound according to claim 5 , wherein L X6 has a structure which is a member selected from:
7. The compound according to claim 1 , wherein the targeting moiety is selected from antibodies, polypeptides, nucleic acids, oligonucleotides, carbohydrates, lipids, hormones, growth factors, lectins, receptor ligands, and cofactors.
8. The compound according to claim 1 , wherein the reactive functional group is selected from:
(i) carboxyl groups, N-hydroxybenztriazole esters, acid halides, acyl imidazoles, thioesters, p-nitrophenyl esters, alkyl, alkenyl, alkynyl and aromatic esters;
(ii) hydroxyl groups;
(iii) haloalkyl groups;
(iv) dienophile groups;
(v) aldehyde or ketone groups;
(vi) alkenes;
(vii) epoxides; and
(ix) phosphoramidites.
9. A complex comprising a compound according to claim 1 and a metal ion complexed therewith.
10. The complex according to claim 9 , wherein the ion is an ion of a metal selected from a lanthanide, and an actinide.
11. The complex according to claim 9 , wherein the ion is an ion of a metal selected from zirconium (Zr), iron (Fe), indium (In), europium (Eu), holmium (Ho), lutetium (Lu), yttrium (Y), terbium (Tb), ytterbium (Yb), gadolinium (Gd), samarium (Sm), dysprosium (Dy), erbium (Er), thorium (Th), calcium (Ca), and magnesium (Mg).
12. The complex according to claim 9 , wherein the complex is luminescent.
13. The complex according to claim 9 , wherein the ion is an ion of a metal selected from Eu, Tb, Sm, and Dy.
14. The complex according to claim 9 , wherein the ion is an ion of Gd.
15. The complex according to claim 9 , wherein the ion is a radionuclide.
16. The complex according to claim 9 , wherein the metal ion is selected from Zr(IV), Fe(III), Sc(III), In(III), Eu(III), Ho(III), Lu(III), Y(III), Tb(III), Yb(III), Gd(III), Sm(III), Dy(III), Er(III), Th(IV), Ca(II), Ac(III), and Mg(II).
17. The complex according to claim 9 , wherein the metal ion is selected from 227 Th(IV), 89 Zr(IV), 225 Ac(III) and 177Lu(III).